43235

Esophagogastroduodenoscopy, flexible, transoral; with biopsy(s)

Esophagogastroduodenoscopy (EGD) with biopsy(s) is a diagnostic endoscopic procedure involving the insertion of a flexible endoscope orally to visualize the mucosa of the esophagus, stomach, and duodenum. During the procedure, one or more tissue samples (biopsies) are obtained from any of these areas for subsequent histological examination. This service includes the comprehensive diagnostic visualization of the upper gastrointestinal tract along with the therapeutic/diagnostic intervention of tissue sampling. It is performed to investigate symptoms, confirm diagnoses, or monitor known conditions within the upper GI system.

Clinical Indications

  • Evaluation of dysphagia, odynophagia, or persistent dyspepsia unresponsive to medical therapy.
  • Investigation of upper gastrointestinal bleeding (e.g., hematemesis, melena, occult blood loss, or iron deficiency anemia of unknown origin).
  • Screening or surveillance for Barrett's esophagus, gastric intestinal metaplasia, or other premalignant conditions.
  • Assessment of suspected inflammatory conditions such as esophagitis, gastritis, duodenitis, celiac disease, or Crohn's disease of the upper GI tract.
  • Evaluation of suspected peptic ulcer disease, H. pylori infection, or gastric polyps.
  • Follow-up of abnormal imaging findings (e.g., barium swallow, CT scan) suggesting upper GI pathology.
  • Investigation of unexplained weight loss, persistent nausea, or vomiting.
  • Confirmation of suspected malignancy (e.g., esophageal or gastric cancer) identified by other means.

Procedure Steps

  1. Patient preparation, including fasting and administration of conscious sedation or general anesthesia, and local anesthetic throat spray.
  2. Careful insertion of the flexible endoscope orally through the pharynx, esophagus, stomach, and into the duodenum (typically to the second portion).
  3. Thorough systematic visualization and examination of the esophageal mucosa, gastroesophageal junction, gastric cardia, fundus, body, antrum, pylorus, and duodenal bulb and descending duodenum.
  4. Identification of areas of abnormality or specific sites for surveillance.
  5. Passage of biopsy forceps through the endoscope's working channel to obtain one or more tissue samples from identified areas of interest or for routine screening protocols.
  6. Careful retrieval and proper labeling of biopsy specimens for histopathological analysis.
  7. Controlled withdrawal of the endoscope.
  8. Post-procedure monitoring of the patient until recovery from sedation.

Coding Guidelines

  • CPT code 43235 includes the diagnostic visualization of the esophagus, stomach, and duodenum. Do not report 43235 with other diagnostic EGD codes for the same session.
  • The 's' in 'biopsy(s)' indicates that one or multiple biopsies performed during the same endoscopic session are covered by this single code; do not append modifiers for additional biopsies.
  • If other distinct therapeutic procedures (e.g., polypectomy, hemostasis, foreign body removal, dilation) are performed during the same EGD session, they may be reported separately in addition to 43235, often requiring a modifier (e.g., -59 or -XU) to indicate a distinct procedural service. Always consult current NCCI (National Correct Coding Initiative) edits for bundling guidelines.
  • Conscious sedation provided by the operating physician may be reported separately with appropriate CPT codes (e.g., 99151-99153) if specific time and documentation requirements are met and it is not explicitly bundled into the primary procedure.
  • Documentation must clearly state the medical necessity for the EGD and the reason(s) for the biopsy(s), including the specific site(s) from which tissue samples were obtained.